Anti-CTLA-4/CD152 Antibody (Nurulimab)
Catalog No.
F1226
Anti-CTLA-4/CD152 Antibody (Nurulimab)
Featured Products
Nurulimab (BCD-145) is an anti-cytotoxic T lymphocyte antigen 4 (anti-CTLA-4) humanized monoclonal antibody. Nurulimab can be used in melanoma research.
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
143.78 kDa
Dry ice
2168561-20-2
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
BCD-145, Anti-CTLA4 MAB
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P16410
Human
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
CTLA-4 / CD152
Please avoid freeze-thaw cycles.